Life sciences news
-
Novalis Biotech closes €25 million Biotech Acceleration Fund
Wednesday June 30th 2021
Read more
-
Biotalys launches its Initial Public Offering on Euronext Brussels
Wednesday June 23rd 2021
Read more
-
Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy
Tuesday June 22nd 2021
Read more
-
Biotalys announces intention to launch an Initial Public Offering on Euronext Brussels
Tuesday June 15th 2021
Read more
-
Montis Biosciences awarded VLAIO grant to expand its pipeline of novel immune-oncology therapeutics
Monday June 14th 2021
Read more
-
RheaVita closes EUR 2.5 million Series A Financing co-led by Novalis Biotech Acceleration and PMV
Wednesday June 2nd 2021
Read more
-
Investment in Flow Cytometry unlocks the secrets of single cells
Thursday May 20th 2021
Read more
-
Droia Ventures raises a new fund of EUR 220 million to target genetic diseases and expands leadership team with George Golumbeski
Tuesday May 11th 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Biocartis receives EUR 1.4m grant to support development of new Idylla™ technology to unlock potential in molecular surveillance
Tuesday May 11th 2021
Read more
-
Biocartis announces US FDA 510(k) submission of its Idylla™ MSI Test
Tuesday April 20th 2021
Read more
-
The European Circular Bioeconomy Fund (ECBF) expands Aphea.Bio Series B funding round to EUR 18 million
Wednesday April 14th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
